Lipodystrophy and human immunodeficiency virus infection

Agriculture & Biology

• HIV infections 100%
• Human immunodeficiency virus 94%
• drugs 44%
• immunosuppression 39%
• exercise 31%
• RNA-directed DNA polymerase 26%
• nutrition 26%
• therapeutics 26%
• nucleosides 24%
• blood lipids 23%
• blood glucose 22%
• drug therapy 22%
• antiretroviral agents 19%
• diet therapy 16%
• diabetes mellitus 14%
• hyperlipidemia 13%
• insulin resistance 13%
• body mass index 13%
• hyperglycemia 13%
• developed countries 12%
• proteinase inhibitors 11%
• morbidity 11%
• diet 11%
• body composition 11%
• surgery 11%
• Taiwan 11%
• developing countries 10%
• public health 10%
• immunity 9%
• adverse effects 9%
• plastics 8%
• death 8%
• hormones 7%
• duration 7%
• gender 6%
• lipids 6%

Medicine & Life Sciences

• Lipodystrophy 90%
• Virus Diseases 49%
• HIV 46%
• Pharmaceutical Preparations 24%
• Nutrition Therapy 23%
• Lipectomy 22%
• Acquired Immunodeficiency Syndrome 21%
• Reverse Transcriptase Inhibitors 20%
• Exercise Therapy 20%
• Diet Therapy 19%
• Nucleosides 17%
• Lipids 10%
• Glucose 10%
• Drug Therapy 9%
• Plastic Surgery 9%
• Protease Inhibitors 8%
• Taiwan 8%
• Body Composition 8%
• Dyslipidemias 8%
• Developed Countries 8%
• Duration of Therapy 7%
• Hyperglycemia 7%
• Epidemics 7%
• Insulin Resistance 6%
• Immunity 6%
• Diabetes Mellitus 6%
• Cause of Death 6%
• Fats 6%
• Body Mass Index 6%
• Public Health 5%
• Hormones 5%
• Diet 5%
• Transplants 5%
• Morbidity 4%
• Mortality 4%
• Therapeutics 4%